These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15108675)

  • 1. FDA approves SQV/r.
    IAPAC Mon; 2004 Jan; 10(1):39. PubMed ID: 15108675
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. Potential serious effect of combination saquinavir-ritonavir.
    AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774
    [No Abstract]   [Full Text] [Related]  

  • 3. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW
    Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA notifications. FDA approves NDA for Lexiva.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
    [No Abstract]   [Full Text] [Related]  

  • 5. New Norvir soft-gel capsule formulation approved by FDA.
    Gaylord G
    Posit Living; 1999 Aug; 8(7):11. PubMed ID: 12492076
    [No Abstract]   [Full Text] [Related]  

  • 6. Roche brings new formulation of saquinavir to FDA. Food and Drug Administration.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):8. PubMed ID: 11364377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA notifications. FDA approves new formulation of Lexiva.
    AIDS Alert; 2007 Aug; 22(8):90-1. PubMed ID: 17768778
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA notifications. FDA approves new dosing for Kaletra.
    AIDS Alert; 2010 Jun; 25(6):70-1. PubMed ID: 20623833
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA notifications. FDA approves new Kaletra formulation.
    AIDS Alert; 2005 Dec; 20(12):142-3. PubMed ID: 16400722
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA approves new dosing for amprenavir and ritonavir combination.
    AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920
    [No Abstract]   [Full Text] [Related]  

  • 11. About the NDA filing.
    AIDS Patient Care STDS; 1997 Dec; 11(6):455. PubMed ID: 11361869
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA approves darunavir.
    AIDS Patient Care STDS; 2008 Dec; 22(12):1021-2. PubMed ID: 19097261
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. Alternative dosing regimen for atazanavir is approved.
    AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
    [No Abstract]   [Full Text] [Related]  

  • 15. Agenerase approved by FDA.
    Gaylord G
    Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
    TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA approves Lexiva.
    IAPAC Mon; 2003 Nov; 9(11):280. PubMed ID: 14989187
    [No Abstract]   [Full Text] [Related]  

  • 18. Reyataz dosing options discussed. Excerpts from the FDA atazanavir hearing.
    Huff B
    GMHC Treat Issues; 2003 Jun; 17(6):8-11. PubMed ID: 12913962
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA approves nelfinavir. Food and Drug Administration.
    GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why the old saquinavir (Invirase) may be bad for your health.
    Vazquez E
    Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.